AYR Wellness Delays Q1 2025 Filing

LOS ANGELES- AYR Wellness Inc. a vertically integrated multi-state cannabis operator in the U.S., has reported a delay in filing its interim financial statements, MD&A, and related CEO/CFO certification for the quarter ended March 31, 2025. The postponement stems from ongoing negotiations with creditors and assessments of accounting classifications for debt obligations being discussed with an ad hoc committee of senior lenders.

The delay coincides with broader strategic initiatives as the company evaluates its capital structure and explores options to support upcoming payment obligations and its long-term growth plan. AYR has not provided a timeline for completing the interim filings but reaffirmed its commitment to resolving outstanding issues and updating stakeholders as appropriate.

As a result of the missed filings, the Ontario Securities Commission has imposed a failure-to-file cease-trade order (FFCTO), which prohibits trading in AYR’s securities across all Canadian jurisdictions. Trading remains suspended on the Canadian Securities Exchange until regulatory requirements are met